Pharmaron (688046.SH): The net income in the first half of the year was 76.3377 million yuan, a year-on-year decrease of 1.59%. It plans to distribute a dividend of 0.3 yuan per share.

Gelonghui Finance · Aug 28 06:19

On August 28, Gelonghui announced its interim report for the first half of 2024. During the reporting period, it achieved revenue of 0.34 billion yuan, a year-on-year increase of 15.05%. The net income attributable to shareholders of the listed company was 76.3377 million yuan, a year-on-year decrease of 1.59%. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 58.4371 million yuan, a year-on-year increase of 10.73%. The basic earnings per share was 0.19 yuan. The company plans to distribute a cash dividend of 0.30 yuan (including tax) per 10 shares to all shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

药康生物(688046.SH)：上半年净利润7633.77万元，同比下降1.59% 拟10派0.3元

Pharmaron (688046.SH): The net income in the first half of the year was 76.3377 million yuan, a year-on-year decrease of 1.59%. It plans to distribute a dividend of 0.3 yuan per share.

Risk Disclaimer

Statement